Tags: psoriasis | cosentyx | treatment

New Psoriasis Drug Clears Skin in 4 Months

Friday, 12 Dec 2014 08:00 AM

Novartis said on Friday its experimental psoriasis drug Cosentyx was better at clearing the rough skin patches associated with the disease than Johnson & Johnson's Stelara.

Results of the late-stage Phase IIIb study involving 679 patients with moderate to severe plaque psoriasis found those taking Cosentyx achieved clear or almost clear skin after 16 weeks of treatment.

On a secondary measure, patients achieved at least a 75 percent improvement in disease severity at week four.
 
Plaque psoriasis is a painful and unsightly skin condition which is known to cause itching and scaling and affects approximately 125 million people.

The data follows results last year showing Cosentyx, also known as secukinumab, was superior to Amgen's Embrel in a head-to-head study.

Cosentyx is expected to be the first in a clutch of new treatments for plaque psoriasis which target the inflammation-causing protein interleukin-17 (IL-17) to gain market approval.

European regulators gave the green light to the drug last month, while an advisory panel to the U.S. Food and Drug Administration unanimously recommended the use of the drug.

Other drugmakers working on new treatments include Eli Lilly, AstraZeneca and Amgen.

© 2017 Thomson/Reuters. All rights reserved.

   
1Like our page
2Share
Health-News
Novartis said on Friday its experimental psoriasis drug Cosentyx was better at clearing the rough skin patches associated with the disease than Johnson Johnson's Stelara. Results of the late-stage Phase IIIb study involving 679 patients with moderate to severe plaque psoriasis...
psoriasis, cosentyx, treatment
187
2014-00-12
Friday, 12 Dec 2014 08:00 AM
Newsmax Inc.
 

The information presented on this website is not intended as specific medical advice and is not a substitute for professional medical treatment or diagnosis. Read Newsmax Terms and Conditions of Service.

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

NEWSMAX.COM
© Newsmax Media, Inc.
All Rights Reserved